These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31069200)

  • 21. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
    van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
    Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
    Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
    Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional Defects in Type 3 Innate Lymphoid Cells and Classical Monocytes in a Patient with Hyper-IgE Syndrome.
    Chang Y; Kang SY; Kim J; Kang HR; Kim HY
    Immune Netw; 2017 Oct; 17(5):352-364. PubMed ID: 29093656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
    Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
    Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
    Freeman AF; Domingo DL; Holland SM
    Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
    Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
    J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
    Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
    Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
    Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs.
    Yoshida Y; Nagamori T; Takahashi H; Ishibazawa E; Shimada S; Kawai T; Azuma H
    Pediatr Int; 2021 May; 63(5):510-515. PubMed ID: 32920916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.
    Hsu AP; Sowerwine KJ; Lawrence MG; Davis J; Henderson CJ; Zarember KA; Garofalo M; Gallin JI; Kuhns DB; Heller T; Milner JD; Puck JM; Freeman AF; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1586-93. PubMed ID: 23623265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review.
    Lan J; Zhang Y; Song M; Cai S; Luo H; OuYang R; Yang P; Shi X; Long Y; Chen Y
    Front Med (Lausanne); 2022; 9():835257. PubMed ID: 35602476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
    Alcántara-Montiel JC; Vega-Torres BI
    Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
    Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
    Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3-confusion-of-function: Beyond the loss and gain dualism.
    Lodi L; Faletti LE; Maccari ME; Consonni F; Groß M; Pagnini I; Ricci S; Heeg M; Simonini G; Azzari C; Ehl S
    J Allergy Clin Immunol; 2022 Nov; 150(5):1237-1241.e3. PubMed ID: 35750105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
    de Silva R; Dasanayake D; Senanayake M; Ediriweera R; Dias S; Karunatilleke C; Brocas K; Tahami F; Seneviratne S
    Allergy Asthma Clin Immunol; 2018; 14():70. PubMed ID: 30410549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome.
    Harrison SC; Tsilifis C; Slatter MA; Nademi Z; Worth A; Veys P; Ponsford MJ; Jolles S; Al-Herz W; Flood T; Cant AJ; Doffinger R; Barcenas-Morales G; Carpenter B; Hough R; Haraldsson Á; Heimall J; Grimbacher B; Abinun M; Gennery AR
    J Clin Immunol; 2021 Jul; 41(5):934-943. PubMed ID: 33523338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
    Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
    Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome.
    Mahdaviani SA; Ghadimi S; Fallahi M; Hashemi-Moghaddam SA; Chavoshzadeh Z; Puel A; Rezaei N; Rekabi M; Daneshmandi Z; Sheikhy K; Kakhki AD; Saghebi SR; Pejhan S; Jamee M
    BMC Surg; 2023 Sep; 23(1):289. PubMed ID: 37741967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.
    Wu J; Hong L; Chen TX
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):51. PubMed ID: 30112673
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.